Indeed, Liu et al. reported that decreased expression of ACTN4 could occur in humans with primary glomerulopathies including sporadic FSGS, minimal change disease, and IgA nephropathy [55]. This evidence concerns the gene ACTN4 and focal segmental glomerulosclerosis.